VivoSim Labs, Inc.
USD1.05
-0.01 (-0.47%)
CEO
Keith Murphy
IPO Date
2012-02-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.06
Prev. Close
$1.06
Day Low
$1.00
Day High
$1.09
52W Low
$0.95
52W High
$5.30
Market Cap
$0.00B
Volume
0.17M
| -0.1 |
| 31 Mar 2023 | FY | 100.0% | -4664.6% | -112.6% | -85.0% | 0.12 | 4.64 | -0.1 |
| 31 Mar 2022 | FY | 100.0% | -763.2% | -37.9% | -34.4% | 0.07 | 21.35 | -0.1 |
| 31 Mar 2021 | FY | 0.0% | 0.0% | -42.9% | -42.2% | 0.00 | 53.26 | -0.1 |
| 31 Mar 2020 | FY | 85.1% | -852.0% | -70.3% | -65.8% | 0.00 | 15.65 | -0.0 |
| 31 Mar 2019 | FY | 84.4% | -861.7% | -73.4% | -65.6% | 0.00 | 10.32 | -0.0 |
| 31 Mar 2018 | FY | 77.6% | -756.1% | -78.1% | -69.8% | 0.00 | 10.04 | -0.0 |
| 31 Mar 2017 | FY | 77.4% | -908.9% | -61.7% | -55.6% | 0.00 | 10.83 | -0.0 |
| 31 Mar 2016 | FY | 100.0% | -2601.1% | -62.0% | -57.1% | 0.00 | 14.18 | -0.0 |
| -0.4 |
| 30 Jun 2025 | Q1 | 100.0% | -7683.8% | -29.8% | -23.7% | 0.09 | 4.52 | -0.2 |
| 31 Mar 2025 | Q4 | 100.0% | 13435.3% | 65.3% | 46.8% | 0.09 | 3.25 | 0.1 |
| 31 Dec 2024 | Q3 | 91.7% | -14362.5% | -947.0% | -89.7% | 2.91 | 0.72 | -0.2 |
| 30 Sept 2024 | Q2 | 96.7% | -8496.7% | -69.3% | -37.7% | 0.32 | 1.98 | -0.3 |
| 30 Jun 2024 | Q1 | 94.9% | -8574.4% | -50.2% | -35.3% | 0.19 | 3.58 | -0.2 |
| 31 Mar 2024 | Q4 | 100.0% | -10500.0% | -84.6% | -48.0% | 0.39 | 2.12 | -0.1 |
| 31 Dec 2023 | Q3 | 100.0% | -72080.0% | -58.3% | -40.6% | 0.24 | 3.67 | -0.1 |
| 30 Sept 2023 | Q2 | 0.0% | 0.0% | -47.2% | -35.8% | 0.19 | 5.18 | -0.1 |